Milan Zdravkovic
Founder chez Selma Diagnostics ApS
Profil
Milan Zdravkovic founded Selma Diagnostics ApS.
He is on the board of Empros Pharma AB and Selma Diagnostics ApS.
Dr. Zdravkovic previously was Chief Medical Officer, Head-Research & Development at Swedish Orphan Biovitrum AB and Vice President of Novo Nordisk Scandinavia AB.
Dr. Zdravkovic received a doctorate from the University of Aarhus, a graduate degree from the University of Surrey and a doctorate from the University of Aarhus.
Postes actifs de Milan Zdravkovic
Sociétés | Poste | Début |
---|---|---|
Selma Diagnostics ApS | Founder | 01/05/2016 |
Empros Pharma AB
Empros Pharma AB Pharmaceuticals: MajorHealth Technology Empros Pharma AB is a pharmaceutical company based in Sweden that focuses on developing drugs to combat obesity. The CEO is Arvid Söderhäll, and the company is located in Solna, Sweden. The Swedish company has developed a weight-loss combination product containing orlistat and acarbose, which has been tested in a randomized, placebo-controlled trial. Empros Pharma's main drug, EMP16, is designed to delay food digestion and absorption processes in the small intestine using a proprietary advanced drug delivery technology. The company was founded in 2013 by senior researchers and entrepreneurs at Uppsala University, along with external investor Flerie Invest. | Director/Board Member | 01/01/2020 |
Anciens postes connus de Milan Zdravkovic
Sociétés | Poste | Fin |
---|---|---|
SWEDISH ORPHAN BIOVITRUM AB | Chief Tech/Sci/R&D Officer | 18/08/2020 |
Novo Nordisk Scandinavia AB
Novo Nordisk Scandinavia AB Pharmaceuticals: MajorHealth Technology Novo Nordisk Scandinavia AB develops, manufactures and markets pharmaceutical products and services. Its products include medicine for diabetes, hemophilia, growth disorders, and hormone therapy. The company is headquartered in Malmö, Sweden. | Corporate Officer/Principal | 01/01/2007 |
PILA PHARMA AB | Director/Board Member | - |
Formation de Milan Zdravkovic
University of Aarhus | Doctorate Degree |
University of Surrey | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 2 |
---|---|
SWEDISH ORPHAN BIOVITRUM AB | Health Technology |
PILA PHARMA AB | Health Technology |
Entreprise privées | 3 |
---|---|
Novo Nordisk Scandinavia AB
Novo Nordisk Scandinavia AB Pharmaceuticals: MajorHealth Technology Novo Nordisk Scandinavia AB develops, manufactures and markets pharmaceutical products and services. Its products include medicine for diabetes, hemophilia, growth disorders, and hormone therapy. The company is headquartered in Malmö, Sweden. | Health Technology |
Empros Pharma AB
Empros Pharma AB Pharmaceuticals: MajorHealth Technology Empros Pharma AB is a pharmaceutical company based in Sweden that focuses on developing drugs to combat obesity. The CEO is Arvid Söderhäll, and the company is located in Solna, Sweden. The Swedish company has developed a weight-loss combination product containing orlistat and acarbose, which has been tested in a randomized, placebo-controlled trial. Empros Pharma's main drug, EMP16, is designed to delay food digestion and absorption processes in the small intestine using a proprietary advanced drug delivery technology. The company was founded in 2013 by senior researchers and entrepreneurs at Uppsala University, along with external investor Flerie Invest. | Health Technology |
Selma Diagnostics ApS |